HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Response to everolimus of a progressive plexiform neurofibroma in Neurofibromatosis type 1.

AuthorsMaria Elena Mateos, Eduardo López-Laso, Josefina Vicente, Rosa Ortega, Fernando Vázquez, Juan Luis Pérez-Navero
JournalPediatrics international : official journal of the Japan Pediatric Society (Pediatr Int) Vol. 62 Issue 7 Pg. 857-859 (07 2020) ISSN: 1442-200X [Electronic] Australia
PMID32027426 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Everolimus
  • TOR Serine-Threonine Kinases
Topics
  • Antineoplastic Agents (therapeutic use)
  • Child
  • Everolimus (therapeutic use)
  • Female
  • Humans
  • Magnetic Resonance Imaging (methods)
  • Neurofibroma, Plexiform (complications, drug therapy)
  • Neurofibromatosis 1 (complications, drug therapy)
  • TOR Serine-Threonine Kinases (metabolism)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: